Bir Dawn Carter - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 26, 2023, Bir Dawn Carter's relationship to REATA PHARMACEUTICALS INC (RETA) is Officer (Chief Commercial Officer), and currently has 0 shares of Class A common stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RETA insiders.

Data Source: SEC.
Bir Dawn Carter - Insider Non-Derivative Transactions of RETA Class A common stock
Bir Dawn Carter - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 27, 2023 Disposition -- (Class A common stock) 33805 0 0
Aug 17, 2023 Sell -- (Class A common stock) 398 168.33 33805
Aug 16, 2023 Sell -- (Class A common stock) 807 169.04 34203
Jul 29, 2023 Sell -- (Class A common stock) 40000 164.54 35010
Jul 29, 2023 C -- (Class A common stock) 40000 0 75010
Jul 7, 2023 Acquisition -- (Class A common stock) 4125 0 35010
May 17, 2023 Sell -- (Class A common stock) 417 80.96 30885
May 16, 2023 Sell -- (Class A common stock) 894 85.09 31302
Mar 14, 2023 Sell -- (Class A common stock) 9317 86.77 32196
Mar 8, 2023 Sell -- (Class A common stock) 200 86.67 41513
Mar 8, 2023 Sell -- (Class A common stock) 5793 85.9 41713
Mar 8, 2023 Sell -- (Class A common stock) 36049 85.08 47506
Mar 8, 2023 C -- (Class A common stock) 41630 0 83555
Mar 7, 2023 Sell -- (Class A common stock) 14820 90.26 41925
Mar 7, 2023 Sell -- (Class A common stock) 40134 89.3 56745
Mar 7, 2023 C -- (Class A common stock) 48370 0 96879
Mar 4, 2023 Sell -- (Class A common stock) 2166 88.25 48509
Jan 4, 2023 Acquisition -- (Class A common stock) 15675 0 50675